Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: The role of advanced glycation end products

Arthritis and Rheumatism

Volumn 44, Issue 11, 2001, Pages 2562-2571

  DeGroot, Jeroen ^a,b   Verzijl, Nicole ^a,b   Wenting Van Wijk, Marion J G ^b   Bank, Ruud A ^a   Lafeber, Floris P J G ^b   Bijlsma, Johannes W J ^b   Tekoppele, Johan M ^a  

^a TNO   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; MATRIX METALLOPROTEINASE; PENTOSIDINE;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; ARGININE; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CATTLE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCOSAMINOGLYCANS; HUMANS; KNEE JOINT; LYSINE; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PHENYLMERCURIC ACETATE; RIBOSE; SYNOVIAL FLUID;

EID: 0035157665     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200111)44:11<2562::AID-ART437>3.0.CO;2-1     Document Type: Article

References (66)

1. Osteoarthritis
2. Rheumatoid arthritis: Pathophysiology and implications for therapy
3. Degradative enzymes in osteoarthritis
4. Matrix proteinases
5. Matrix metalloproteinases
6. Aggrecan degradation in human cartilage: Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints
7. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts: Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression
8. Collagenase and collagenolytic activity in human osteoarthritic cartilage
9. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media
10. Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay
11. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis
12. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury
13. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1)
14. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage
15. Aggrecan is degraded by matrix metalloproteinases in human arthritis: Evidence that matrix metalloproteinase and aggrecanase activities can be independent
16. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein
17. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)
18. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
19. The structure of aggrecan fragments in human synovial fluid: Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis
20. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis
21. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases: Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation
22. Clinical trials of a stromelysin inhibitor: Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications
23. Nonenzymatic glycation of collagen in aging and diabetes
24. Effect of collagen turnover on the accumulation of advanced glycation end products
25. Racemization of aspartic acid in human articular cartilage
26. Age-related accumulation of Maillard reaction products in human articular cartilage collagen
27. Structure elucidation of a senescence cross-link from human extracellular matrix: Implication of pentoses in the aging process
28. Nonenzymatic glycation of cartilage proteoglycans: An in vivo and in vitro study
29. Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders
30. Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage: The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage
31. Age-related decrease in proteoglycan synthesis of human articular chondrocytes: The role of nonenzymatic glycation
32. Glycation changes the charge distribution of type I collagen fibrils
33. Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen
34. Reduced susceptibility of nonenzymatically glucosylated glomerular basement membrane to proteases: Is thickening of diabetic glomerular basement membranes due to reduced proteolytic degradation?
35. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
36. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
37. Comparison of normal and in vitro aging by non-enzymatic glycation as verified by differential scanning calorimetry
38. Age-related association of tail tendon break time with tissue pentosidine in DBA/2 vs C57BL/6 mice: The effect of dietary restriction
39. Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts
40. Nonenzymatic glycation of mesangial matrix and prolonged exposure of mesangial matrix to elevated glucose reduces collagen synthesis and proteoglycan charge
41. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage
42. Age-related changes in aggrecan glycosylation affect cleavage by aggrecanase
43. Formation of pentosidine during nonenzymatic browning of proteins by glucose: Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo
44. Amino acid analysis by reverse-phase high-performance liquid chromatography: Improved derivatization and detection conditions with 9-fluorenylmethyl chloroformate
45. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
46. Blood-induced joint damage: A human in vitro study
47. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4
48. Fluorogenic MMP activity assay for plasma including MMPs complexed to alpha 2-macroglobulin
49. Generation and characterization of aggrecanase: A soluble, cartilage-derived aggrecan-degrading activity
50. Differential expression of aggrecanase and matrix metalloproteinase activity in chondrocytes isolated from bovine and porcine articular cartilage
51. Imbalance of proteinases and their inhibitors in osteoarthritis
52. Breakers of advanced glycation end products restore large artery properties in experimental diabetes
53. Isolation and partial characterization of collagen chains dimerized by sugar-derived cross-links
54. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan
55. Degradation of cartilage aggrecan by collagenase-3 (MMP-13)
56. Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis
57. Generation and novel distribution of matrix metalloproteinase-derived aggrecan fragments in porcine cartilage explants
58. The biochemistry of cartilage and the biochemical changes in osteoarthritis
59. The increased swelling and instantaneous deformation of osteoarthritic cartilage is highly correlated with collagen degradation
60. Age-related changes in the synthesis of link protein and aggrecan in human articular cartilage: Implications for aggregate stability
61. Further studies on the composition of human femoral head cartilage
62. Mechanisms of maturation and ageing of collagen
63. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence
64. Imbalances of anabolism and catabolism of cartilage matrix components in osteoarthritis
65. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments